ARCA biopharma, Inc. (ABIO) Social Stream



ARCA biopharma, Inc. (ABIO): $28.80

1.20 (-4.00%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add ABIO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#209 of 338

in industry

ARCA biopharma Inc (ABIO) Price Targets From Analysts

Use the tables below to see what analysts covering ARCA biopharma Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
1 $7 $7 $7 $2.68 161.19%

Price Target Last Issued February 23, 2021

The Trend in the Analyst Price Target


Over the past 52 days, ABIO's average price target has gone down $0.

Over the past 42 weeks, ABIO's average upside potential has been 59.82%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-02-23 1 7 7 7 4.68 49.57%
2021-02-20 1 7 7 7 4.75 47.37%
2021-02-13 1 7 7 7 5.18 35.14%
2021-02-06 1 7 7 7 4.66 50.21%
2021-01-30 1 7 7 7 4.20 66.67%
2021-01-23 1 7 7 7 4.66 50.21%
2021-01-16 1 7 7 7 4.45 57.3%
2021-01-09 1 7 7 7 4.22 65.88%
2021-01-02 1 7 7 7 4.01 74.56%
2020-12-26 1 7 7 7 4.25 64.71%
2020-12-19 1 7 7 7 4.00 75%
2020-12-09 1 7 7 7 4.12 69.9%
2020-12-07 1 7 7 7 4.09 71.15%
2020-05-04 1 7 7 7 NA NA%

ABIO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • ABIO has a greater number of analysts covering the stock than nearly none of all US stocks.
  • ARCA biopharma Inc's variance in analysts' estimates is lower than just about 100% of all US stocks.
  • The average analyst price target of ABIO is higher than 12.73% of all US stocks.
  • The upside potential (average analyst target price relative to current price) of ABIO is greater than 86.93% of all US stocks.

Make investment decisions regarding ABIO using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!